Response to comment on "Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer"

被引：0
|
作者：
van der Doelen, Maarten J. [1 ,2 ]
Slootbeek, Peter H. J. [1 ]
Mehra, Niven [1 ]
机构：
[1] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, POB 9101, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Urol, Nijmegen, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 2021年 / 144卷
关键词：
D O I：
10.1016/j.ejca.2020.11.041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：395 / 396
页数：2
相关论文
共 50 条
  • [31] Outcomes and patterns of use of Radium-223 in metastatic castration-resistant prostate cancer
    Anido-Herranz, Urbano
    Fernandez-Calvo, Ovidio
    Ruiz-Banobre, Juan
    Martinez-Breijo, Sara
    Fernandez-Nunez, Natalia
    Nogareda-Seoane, Zulema
    Garrido-Pumar, Miguel
    Casas-Nebra, Javier
    Muniz-Garcia, Gloria
    Portela-Pereira, Paula
    Gomez-Caamano, Antonio
    Perez-Fentes, Daniel Adolfo
    Santome-Couto, Lucia
    Lazaro, Martin
    Molina-Diaz, Aurea
    Medina-Colmenero, Ana
    Vazquez-Estevez, Sergio
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [32] The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases
    Ram, Prasanna
    Mandal, Swarnendu
    Das, Manoj K.
    Nayak, Prasant
    PROSTATE, 2023, 83 (06): : 613 - 613
  • [33] The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases
    Liu, Alex J.
    Kosiorek, Heidi E.
    Ueberroth, Benjamin E.
    Jaeger, Ellen
    Ledet, Elisa
    Kendi, Ayse T.
    Tzou, Katherine
    Quevedo, Fernando
    Choo, Richard
    Moore, Cassandra N.
    Ho, Thai H.
    Singh, Parminder
    Keole, Sameer R.
    Wong, William W.
    Sartor, Oliver
    Bryce, Alan H.
    PROSTATE, 2022, 82 (12): : 1202 - 1209
  • [34] Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
    Du, Yong
    Carrio, Ignasi
    De Vincentis, Giuseppe
    Fanti, Stefano
    Ilhan, Harun
    Mommsen, Caroline
    Nitzsche, Egbert
    Sundram, Francis
    Vogel, Wouter
    Oyen, Wim
    Lewington, Val
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (10) : 1671 - 1678
  • [35] Impact of treatment delay in Radium-223 therapy of metastatic castration-resistant prostate cancer patients
    Fosbol, Marie Obro
    Petersen, Peter Meidahl
    Daugaard, Gedske
    Holm, Soren
    Kjaer, Andreas
    Mortensen, Jann
    ANNALS OF NUCLEAR MEDICINE, 2018, 32 (01) : 16 - 21
  • [36] Impact of treatment delay in Radium-223 therapy of metastatic castration-resistant prostate cancer patients
    Marie Øbro Fosbøl
    Peter Meidahl Petersen
    Gedske Daugaard
    Søren Holm
    Andreas Kjaer
    Jann Mortensen
    Annals of Nuclear Medicine, 2018, 32 : 16 - 21
  • [37] Pain response in a population-based study of radium-223 (Ra223) for metastatic castration-resistant prostate cancer
    Parimi, Sunil
    Bondy, Suraya
    Tsang, Erica
    McKenzie, Michael Ross
    Bachand, Francois
    Aparicio, Maria
    Duncan, Graeme
    Sunderland, Katherine
    Olson, Robert Anton
    Pai, Howard Huaihan
    Alexander, Abraham Skaria
    LaPointe, Vincent
    Chi, Kim N.
    Tyldesley, Scott
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2019, 13 (10): : E311 - E316
  • [38] The Timing of Radium-223 Therapy in Castration-Resistant Prostate Cancer
    Sartor, Oliver
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (09) : 570 - 572
  • [39] The impact of genetic mutations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases.
    Liu, Alex John
    Kosiorek, Heidi E.
    Ueberroth, Benjamin Edward
    Kendi, Ayse T.
    Tzou, Katherine S.
    Quevedo, Fernando
    Choo, Richard
    Moore, Cassandra N.
    Ho, Thai Huu
    Singh, Parminder
    Keole, Sameer R.
    Wong, William
    Bryce, Alan Haruo
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] Circulating Tumor Cells as a Biomarker of Survival and Response to Radium-223 Therapy: Experience in a Cohort of Patients With Metastatic Castration-Resistant Prostate Cancer
    Caries, Joan
    Castellano, Daniel
    Mendez-Vidal, Maria-Jose
    Mellado, Begona
    Saez, Maria-Isabel
    Gonzalez del Alba, Aranzazu
    Perez-Gracia, Jose-Luis
    Jimenez, Jose
    Suarez, Cristina
    Sepulveda, Juan M.
    Manneh, Ray
    Porras, Ignacio
    Lopez, Cristina
    Morales-Barrera, Rafael
    Arranz, Jose-Angel
    CLINICAL GENITOURINARY CANCER, 2018, 16 (06) : E1133 - E1139
12345